Sort
21,281 grants matching “influenza”
Paramyxoviruses as Vaccine Vectors Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
$787,601Ursula Buchholz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS): UNIVERSAL INFLUENZA RESEARCH EFFORTS
$787,556Walter A. Orenstein · Emory University · N01 · FY2018 · AI
Behavioral Epidemiology: Applications of Agent-Based Modeling to Infectious Disea
$787,446Joshua M. Epstein · Johns Hopkins University · DP1 · FY2013 · GM
A Multi-Omics Approach to the Examination of Bacterial Co-pathogens
$787,248David A Rasko · University Of Maryland Baltimore · U19 · FY2022 · AI
Determinants of Functional Immune Defects in Treated HIV Infection and Aging
$786,968Peter W Hunt · University Of California, San Francisco · R01 · FY2017 · AI
Effects of obesity on the dynamics of Influenza transmission
$786,815Stacey L Schultz-Cherry · St. Jude Children'S Research Hospital · R01 · FY2020 · AI
Enhanced Surveillance for New Vaccine Preventable Diseases
$786,604Mary A Staat · Cincinnati Childrens Hosp Med Ctr · U01 · FY2007 · IP
Role of IgE in Homeostasis and Disease
$786,582Ruslan Medzhitov · Yale University · R01 · FY2025 · AI
Antiviral agents directed to novel targets in the adenovirus proteinase
$786,554Walter F. Mangel · Brookhaven Science Assoc-Brookhaven Lab · R01 · FY2010 · AI
Engineering sustainable squalene analogues for novel vaccine adjuvant emulsions
$786,095Christopher B Fox · Access To Advanced Health Institute · R01 · FY2022 · AI
Translational Geroscience Network
$786,034James L. Kirkland · Mayo Clinic Rochester · R33 · FY2020 · AG
Immunoprotective Properties of Tissue-resident Memory T Cells in Mice and Humans within Mucosal Sites
$785,945Joshua Tisdell Schiffer · Fred Hutchinson Cancer Research Center · R01 · FY2020 · AI
Adjuvants for Skin Immunization: Discovery and Mechanisms
$785,860Ioanna Skountzou · Emory University · R01 · FY2016 · AI
A Comprehensive Pre-Natal Intervention to Increase Vaccine Coverage
$785,845Saad B. Omer · Emory University · R01 · FY2016 · AI
COVID-19 - Global Mix / Investigation of COVID-19 Disease Parameters for Transmission Models in Low-Resource Settings
$785,776Saad B. Omer · Yale University · R01 · FY2022 · AI
Enhanced Surveillance-Newly Vaccine Preventable Diseases
$785,744Peter G Szilagyi · University Of Rochester · U01 · FY2007 · IP
Enhanced Surveillance: New Vaccine Preventable Diseases
$785,743Kathryn Margaret Edwards · Vanderbilt University · U01 · FY2007 · IP
Ex vivo interrogation of the genetic and biochemical networks controlling influe
$785,740Megan Louise Shaw · Icahn School Of Medicine At Mount Sinai · U19 · FY2013 · AI
Kansas City - New Vaccine Surveillance Network (KC-NVSN)
$785,715Rangaraj Selvarangan · Children'S Mercy Hosp (Kansas City, Mo) · U01 · FY2016 · IP
New Vaccine Surveillance Network
$785,715John V Williams · University Of Pittsburgh At Pittsburgh · U01 · FY2016 · IP
Enhanced Surveillance for Newly preventable Diseases (ARI and AGE Surveillance) Rochester, NY
$785,715Geoffrey Alan Weinberg · University Of Rochester · U01 · FY2016 · IP
Enhanced Surveillance for New Vaccine Preventable Diseases
$785,715Julie Anne Boom · Texas Children'S Hospital · U01 · FY2016 · IP
Enhanced Surveillance for New Vaccine Preventable Diseases
$785,715Janet A Englund · Seattle Children'S Hospital · U01 · FY2016 · IP
Enhanced Surveillance for New Vaccine Preventable Diseases
$785,699Natasha Bassam Halasa · Vanderbilt University Medical Center · U01 · FY2016 · IP
Flu SAFE: Flu SMS Alerts to Freeze Exposure
$785,611Melissa S Stockwell · Columbia University Health Sciences · R01 · FY2019 · AI